ConductScience.org, home

Paper36948506

Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor).

Siddiqui BA and 20 others. J Immunother Cancer, 2023. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor). Papers, record 36948506. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36948506

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor).
PubMed
Journal
J Immunother Cancer
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
1.53
iCite
Revised in PubMed
2023-12-23
PubMed

Authors21

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Siddiqui BABilal Ahttps://orcid.org/0000-0002-6806-1294
2Chapin BFBrian F
3Jindal SSonali
4Duan FFei
5Basu SSreyashihttps://orcid.org/0000-0002-5028-3833
6Yadav SSShalini S
7Gu ADAi-Di
8Espejo ABAlexsandra Bhttps://orcid.org/0000-0002-8841-7219
9Kinder MMichelle
10Pettaway CACurtis A
11Ward JFJohn F
12Tidwell RSSRebecca S Shttps://orcid.org/0000-0003-3041-8582
13Troncoso PPatricia
14Corn PGPaul G
15Logothetis CJChristopher J
16Knoblauch RRoland
17Hutnick NNatalie
18Gottardis MMarco
19Drake CGCharles G
20Sharma PPadmanee

Source PubMed

See all 21 authorsDownload CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Prostatic NeoplasmsMajor topic
Male
Humans
Leukocytes, Mononuclear
Antibodies, Monoclonal
Immunosuppressive Agents
Tumor Microenvironment

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P50 CA140388NCI NIH HHSUnited StatesP50CA140388PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129702148Immunomodulatory effects of CD38-targeting antibodies.Immunol Lett2018https://conductscience.org/library/papers/29702148PubMed
229231133Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.N Engl J Med2018https://conductscience.org/library/papers/29231133PubMed
333329591CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity.Front Immunol2020https://conductscience.org/library/papers/33329591PubMed
434663638
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment.
J Immunother Cancer2021https://conductscience.org/library/papers/34663638PubMed
535663534Clinical Development of Colony-Stimulating Factor 1 Receptor (CSF1R) Inhibitors.J Immunother Precis Oncol2021https://conductscience.org/library/papers/35663534PubMed
634655533
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial.
Lancet Oncol2021https://conductscience.org/library/papers/34655533PubMed
731324781Deletion of a Csf1r enhancer selectively impacts CSF1R expression and development of tissue macrophage populations.Nat Commun2019https://conductscience.org/library/papers/31324781PubMed
828321130Effective combinatorial immunotherapy for castration-resistant prostate cancer.Nature2017https://conductscience.org/library/papers/28321130PubMed
932302573Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer.Cell2020https://conductscience.org/library/papers/32302573PubMed
1025628399An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma.Clin Cancer Res2015https://conductscience.org/library/papers/25628399PubMed
1125255802Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer.J Natl Cancer Inst2014https://conductscience.org/library/papers/25255802PubMed
1228596308Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.Science2017https://conductscience.org/library/papers/28596308PubMed
1327222480Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma.Blood2016https://conductscience.org/library/papers/27222480PubMed
1429950727IL-23 secreted by myeloid cells drives castration-resistant prostate cancer.Nature2018https://conductscience.org/library/papers/29950727PubMed
1530589920Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade.JAMA Oncol2019https://conductscience.org/library/papers/30589920PubMed
1611179357Aberrant macrophage and neutrophil population dynamics and impaired Th1 response to Listeria monocytogenes in colony-stimulating factor 1-deficient mice.Infect Immun2001https://conductscience.org/library/papers/11179357PubMed
1728239471Gene expression markers of Tumor Infiltrating Leukocytes.J Immunother Cancer2017https://conductscience.org/library/papers/28239471PubMed
1833046869Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma.Nat Med2020https://conductscience.org/library/papers/33046869PubMed
1928716061Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.J Immunother Cancer2017https://conductscience.org/library/papers/28716061PubMed
2026289091Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression.Cancer Immunol Immunother2015https://conductscience.org/library/papers/26289091PubMed

See all 37 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42846924The multifaceted roles of tumor-infiltrating plasma cells in cancer immunology.Fundam Res2026https://conductscience.org/library/papers/42846924PubMed
42806985Dual blockade of adenosine A2A and A2B receptors is required to reverse NECA-induced immunosuppression in human macrophages: Implications for cancer immunotherapy.Front Immunol2026https://conductscience.org/library/papers/42806985PubMed
42805760Temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggest a window of opportunity for checkpoint inhibitor therapy in prostate cancer.J Immunother Cancer2026https://conductscience.org/library/papers/42805760PubMed
42653263Molecular Mechanisms and Immune Regulation in Prostate Cancer: A Review.Int J Mol Sci2026https://conductscience.org/library/papers/42653263PubMed
42022555Characteristics and therapeutic resistance mechanisms of the prostate cancer immune microenvironment: a comprehensive analysis from bench to clinic.Front Pharmacol2026https://conductscience.org/library/papers/42022555PubMed
41870750CX3CL1-CX3CR1 signaling orchestrates malignant progression of prostate cancer through luminal progenitor-macrophage crosstalk.Cell Oncol (Dordr)2026https://conductscience.org/library/papers/41870750PubMed
41734994The path forward for T cell engagers in patients with prostate cancer.J Immunother Cancer2026https://conductscience.org/library/papers/41734994PubMed
41710886Regulating the regulators via targeting CD38 in the tumor microenvironment.Front Immunol2026https://conductscience.org/library/papers/41710886PubMed
41367012The real-world safety profile and potential mechanism of isatuximab: Integration of pharmacovigilance and transcriptomic analysis.Medicine (Baltimore)2025https://conductscience.org/library/papers/41367012PubMed
41020944Multi-omics genetic study revealing ferroptosis regulator CTSB driving prostate cancer progression by modulating the immune microenvironment.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41020944PubMed
40422244Tumor-Associated Macrophages: Polarization, Immunoregulation, and Immunotherapy.Cells2025https://conductscience.org/library/papers/40422244PubMed
39633050Evolution of myeloid-mediated immunotherapy resistance in prostate cancer.Nature2025https://conductscience.org/library/papers/39633050PubMed
39457618Macrophages as Potential Therapeutic Targets in Acute Myeloid Leukemia.Biomedicines2024https://conductscience.org/library/papers/39457618PubMed
38605951New insights into the role of macrophages in cancer immunotherapy.Front Immunol2024https://conductscience.org/library/papers/38605951PubMed
38565910Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer.Prostate Cancer Prostatic Dis2025https://conductscience.org/library/papers/38565910PubMed
37958472Potential Associations between Vascular Biology and Hodgkin's Lymphoma: An Overview.Cancers (Basel)2023https://conductscience.org/library/papers/37958472PubMed

Download CSV of cited by

Genes29

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD14929PubTator's text mininghttps://conductscience.org/library/genes/929NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD33945PubTator's text mininghttps://conductscience.org/library/genes/945NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD68968PubTator's text mininghttps://conductscience.org/library/genes/968NCBI Gene
CD80941PubTator's text mininghttps://conductscience.org/library/genes/941NCBI Gene
CD86942PubTator's text mininghttps://conductscience.org/library/genes/942NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CSF11435PubTator's text mininghttps://conductscience.org/library/genes/1435NCBI Gene
CSF1R1436PubTator's text mininghttps://conductscience.org/library/genes/1436NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
ENTPD1953PubTator's text mininghttps://conductscience.org/library/genes/953NCBI Gene
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene
FUT42526PubTator's text mininghttps://conductscience.org/library/genes/2526NCBI Gene
HAVCR284868PubTator's text mininghttps://conductscience.org/library/genes/84868NCBI Gene
IL23A51561PubTator's text mininghttps://conductscience.org/library/genes/51561NCBI Gene
IL2RA3559PubTator's text mininghttps://conductscience.org/library/genes/3559NCBI Gene
IL7R3575PubTator's text mininghttps://conductscience.org/library/genes/3575NCBI Gene

See all 29 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36948506

GET https://conductscience.org/api/papers/v1/36948506/authors?page=2